AtriCure, Inc.
ATRC
$37.90
$0.2350.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.09% | 13.57% | 16.64% | 17.93% | 15.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.09% | 13.57% | 16.64% | 17.93% | 15.21% |
| Cost of Revenue | 17.78% | 12.36% | 18.45% | 19.23% | 23.42% |
| Gross Profit | 16.86% | 13.98% | 16.04% | 17.50% | 12.67% |
| SG&A Expenses | 6.51% | 5.13% | 6.65% | 18.89% | 14.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.31% | 8.19% | 20.47% | 15.92% | 17.03% |
| Operating Income | 13.62% | 45.46% | -67.55% | 8.46% | -57.33% |
| Income Before Tax | 23.55% | 50.27% | -62.51% | 16.40% | -54.33% |
| Income Tax Expenses | 3.16% | 30.60% | -28.69% | 585.11% | 172.04% |
| Earnings from Continuing Operations | 22.70% | 49.15% | -59.04% | 13.27% | -56.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.70% | 49.15% | -59.04% | 13.27% | -56.47% |
| EBIT | 13.62% | 45.46% | -67.55% | 8.46% | -57.33% |
| EBITDA | 61.34% | 86.54% | -116.02% | 37.73% | -170.59% |
| EPS Basic | 24.02% | 49.86% | -56.74% | 14.56% | -54.34% |
| Normalized Basic EPS | 24.78% | 45.28% | -60.14% | 17.64% | -40.74% |
| EPS Diluted | 24.02% | 49.86% | -56.74% | 14.56% | -54.34% |
| Normalized Diluted EPS | 24.78% | 45.28% | -60.14% | 17.64% | -40.74% |
| Average Basic Shares Outstanding | 1.73% | 1.44% | 1.46% | 1.50% | 1.39% |
| Average Diluted Shares Outstanding | 1.73% | 1.44% | 1.46% | 1.50% | 1.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |